The reported prevalence of malnutrition and related factors in gynecologic cancer varies. We aimed to describe nutritional status and to identify demographic, clinical, psychological, and nutritional factors contributing to malnutrition in gynecologic cancer patients. We used a descriptive cross-sectional design. A total of 129 subjects were enrolled. Subjects agreed to undergo a face-to-face interview, including measurement of body mass index (BMI) and administration of structured questionnaires including the Patient-Generated Subjective Global Assessment (PG-SGA), the Beck Depression Inventory (BDI), and the Simplified Nutritional Appetite Questionnaire (SNAQ). Mean BMI was 23.4 kg/m2 (range, 14.6–36.7 kg/m2) and median body weight was 55.0 kg (range, 38.5–91.3 kg). Sixty-nine (53.5 %) of 129 patients reported severe malnutrition according to the PG-SGA. Malnutrition among patients who had received chemotherapy was more common than among patients who had not received chemotherapy within 6 months. Depression and appetite were significant factors predicting malnutrition in patients with gynecologic cancer. However, malnutrition was not related to age, marital status, level of education, or annual income among demographic factors, nor age at onset of cancer, cancer type, stage, or duration of cancer among clinical factors. Assessment of nutritional status should be considered along with depression and appetite in patients with gynecologic cancer. In addition, regular and consistent nutritional assessment is essential in gynecologic cancer patients because of the high prevalence of malnutrition in these patients.
BACKGROUND: COPD is one of the most common respiratory diseases. Patients with COPD experience and suffer from various physical and psychological symptoms. We performed this study to identify symptom clusters and the effects on quality of life (QOL) in patients with COPD. METHODS: A total of 130 COPD subjects were recruited from a university hospital in South Korea. Dyspnea, fatigue, depression, anxiety, sleep disturbance, dry mouth, and physical functional status were assessed with structured questionnaires. QOL was measured with the Clinical COPD Questionnaire. Factor analysis and cluster analysis were used to identify symptom clusters based on severity of symptom experiences. RESULTS: Three distinct clusters were identified: a respiratory-functional cluster (symptom cluster 1), a mood cluster (symptom cluster 2), and a fatigue-sleep cluster (symptom cluster 3). Symptom cluster 1 consisted of dyspnea, physical functional status, and dry mouth; symptom cluster 2 consisted of anxiety and depression; and symptom cluster 3 consisted of sleep disturbance and fatigue. Subgroup cluster analysis showed that COPD subjects with higher-scoring symptoms in symptom clusters 1, 2, and 3 had significantly poorer QOL. The symptom clusters were significantly different depending on age, educational level, and monthly income. CONCLUSIONS: COPD subjects may have specific patterns of symptom clusters. The symptom clusters are related with clinical characteristics and had a negative impact on QOL. To enhance symptom management and QOL, approaches and interventions based on symptom clusters, rather than independent intervention for each symptom, may be more effective. Understanding COPD symptom clusters may help successful symptom management, which can improve QOL for COPD patients.